RGA (NYSE: RGA) EVP Senan O'Loughlin reports initial stock and equity awards
Rhea-AI Filing Summary
REINSURANCE GROUP OF AMERICA INC Executive Vice President Senan O'Loughlin filed an initial ownership report showing existing equity awards and holdings. The filing lists 2,967.412 shares of common stock held directly, plus multiple stock appreciation rights that can convert into common shares at preset exercise prices.
The report also details stock appreciation rights granted in 2022, 2023, 2024, 2025, and 2026, with exercise prices between $106.53 and $200.50 per share and expirations from 2032 through 2036. In addition, restricted share units from March 2024, 2025, and 2026 representing 142, 291, and 539 underlying common shares are disclosed, which vest in scheduled annual increments.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
O'Loughlin Senan
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Share Unit - March 2026 | -- | -- | -- |
| holding | Restricted Share Unit - March 2025 | -- | -- | -- |
| holding | Restricted Share Unit - March 2024 | -- | -- | -- |
| holding | Stock Appreciation Right (right to purchase) 2026 | -- | -- | -- |
| holding | Stock Appreciation Right (right to purchase) 2025 | -- | -- | -- |
| holding | Stock Appreciation Right (right to purchase) 2024 | -- | -- | -- |
| holding | Stock Appreciation Right (right to purchase) 2023 | -- | -- | -- |
| holding | Stock Appreciation Right (right to purchase) 2022 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Share Unit - March 2026 — 539 shares (Direct);
Restricted Share Unit - March 2025 — 291 shares (Direct);
Restricted Share Unit - March 2024 — 142 shares (Direct);
Stock Appreciation Right (right to purchase) 2026 — 1,556 shares (Direct);
Stock Appreciation Right (right to purchase) 2025 — 1,190 shares (Direct);
Stock Appreciation Right (right to purchase) 2024 — 1,081 shares (Direct);
Stock Appreciation Right (right to purchase) 2023 — 964 shares (Direct);
Stock Appreciation Right (right to purchase) 2022 — 1,263 shares (Direct);
Common Stock — 2,967.412 shares (Direct)
Footnotes (5)
- F1. Stock appreciation rights and restricted share units settle in common stock, vest in 33 1/3% increments, beginning on the first anniversary date of the grant, and fully vest on March 19, 2029.
- F2. Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock upon vesting.
- F3. Stock appreciation rights and restricted share units settle in common stock, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2027.
- F4. Stock appreciation rights and restricted share units settle in common stock, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2026.
- F5. Stock appreciation rights settle in common stock and vest in 25% increments, over four years, beginning on December 31 of the year of grant.
Key Figures
Direct common stock: 2,967.412 shares
SAR 2022 exercise price: $106.53 per share
SAR 2023 exercise price: $138.34 per share
+5 more
8 metrics
Direct common stock
2,967.412 shares
Directly held common stock following reported holdings
SAR 2022 exercise price
$106.53 per share
Stock appreciation right 2022, expiration in 2032
SAR 2023 exercise price
$138.34 per share
Stock appreciation right 2023, expiration in 2033
SAR 2026 exercise price
$200.50 per share
Stock appreciation right 2026, expiration in 2036
SAR 2026 underlying shares
1,556 shares
Underlying common shares for 2026 stock appreciation right
RSU March 2024
142 shares
Restricted share units March 2024, each for one common share
RSU March 2025
291 shares
Restricted share units March 2025, contingent right to common shares
RSU March 2026
539 shares
Restricted share units March 2026, contingent right to common shares
Key Terms
Stock appreciation rights, Restricted share units, vest in 33 1/3% increments, Executive Vice President, +1 more
5 terms
Stock appreciation rights financial
"Stock appreciation rights settle in common stock and vest in 25% increments, over four years"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
vest in 33 1/3% increments financial
"Stock appreciation rights and restricted share units settle in common stock, vest in 33 1/3% increments"
Executive Vice President financial
"Senan O'Loughlin serves as Executive Vice President of the issuer"
An executive vice president is a high-ranking leader within a company who oversees major parts of its operations or strategies. Think of them as senior managers responsible for important areas, similar to a vice principal in a school hierarchy. Their role matters to investors because they help guide the company's success and decision-making at the top level.
contingent right to receive financial
"Each restricted stock unit represents a contingent right to receive one (1) share"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Senan O'Loughlin's Form 3 filing for RGA show about his holdings?
The Form 3 shows Senan O'Loughlin directly holds 2,967.412 shares of REINSURANCE GROUP OF AMERICA common stock, plus several stock appreciation rights and restricted share units that can convert into additional common shares as they vest or are exercised over future years.
What stock appreciation rights are listed for Senan O'Loughlin in the RGA Form 3?
The filing lists stock appreciation rights granted in 2022, 2023, 2024, 2025, and 2026, each tied to RGA common stock. These rights have exercise prices ranging from $106.53 to $200.50 per share and expiration dates between 2032 and 2036, with specified underlying share amounts.
What future vesting schedule is described for Senan O'Loughlin's RGA equity awards?
The Form 3 footnotes state that certain stock appreciation rights and restricted share units vest in 33 1/3% increments over three years or in 25% increments over four years. Some awards are scheduled to fully vest on dates including December 31, 2026, December 31, 2027, and March 19, 2029.